✅ #ENVISAGE-TAVI AF trial: edoxaban is noninferior to warfarin and its analogues for adverse clinical events in patients with #AFIb after #TAVI
📖#ESCCongress
✨Join Us✨
📲 http://tttttt.me/Irathero 💫
📖#ESCCongress
✨Join Us✨
📲 http://tttttt.me/Irathero 💫
✅ #APAF-CRT trial: ablation plus #CRT is superior to pharmacological rate control in reducing mortality in severely symptomatic permanent #AFib patients with a narrow QRS
📖#ESCCongress
✨Join Us✨
📲 http://tttttt.me/Irathero 💫
📖#ESCCongress
✨Join Us✨
📲 http://tttttt.me/Irathero 💫
✅#DECAAF II trial: fibrosis #ablation shows promise in #AFib with low grade fibrotic myopathy
📖#ESCCongress
✨Join Us✨
📲 http://tttttt.me/Irathero 💫
📖#ESCCongress
✨Join Us✨
📲 http://tttttt.me/Irathero 💫